Melinta Therapeutics, Inc.
melinta.comTotal trials
32
Active
0
Phase 3
12
Total enrollment
9,235
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Healthy5
- Skin and Subcutaneous Tissue Bacterial Infections3
- Abscess3
- Community-acquired Bacterial Pneumonia3
- Bacterial Skin Diseases2
- Staphylococcal Skin Infections2
- Wound Infection2
- Systemic Inflammation2
Frequently asked questions about Melinta Therapeutics, Inc.
- How many clinical trials does Melinta Therapeutics, Inc. have on ClinicalTrials.gov?
- Melinta Therapeutics, Inc. is listed as the lead sponsor on 32 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Melinta Therapeutics, Inc.'s trials are in Phase 3?
- 12 of Melinta Therapeutics, Inc.'s trials are in Phase 3.
- What therapeutic areas does Melinta Therapeutics, Inc. focus on?
- Melinta Therapeutics, Inc.'s most-studied conditions on ClinicalTrials.gov are Healthy, Skin and Subcutaneous Tissue Bacterial Infections, Abscess, Community-acquired Bacterial Pneumonia, Bacterial Skin Diseases.